招商证券主要观点如下： 浆料是电池制造的关键材料，影响电池效率表现 太阳能电池整体结构基于大面积的PN结，在光照条件下光生电子将通过印刷在电池表面的细栅、主栅 汇集，经由焊带至外电路对外做功，实现光能向电能的转化。电池片正背面栅线由浆料印刷制成，实现 电池片层级的汇流，按形态、功能分为细栅、主栅，其图形设计影响电池受光量，材料配方等影响复合 表现，决定其等效电阻，因而浆料对光伏电池光电转换效率及组件性能表现极为关键。 "银"大于"硅"，降银提供最大的潜在降本空间 过去电池浆料以银体系为主，银价大幅上涨后，电池非硅成本中浆料占比跃升，以主流TOPCon电池为 例，单瓦成本由6分左右跃升至0.1-0.2元(考虑银价波动)，已经超过硅料，成为电池成本第一大项，降银 单耗成为产业链降本的重点。 智通财经APP获悉，招商证券发布研报称，近年来银价持续上升，尤其2025年大涨后浆料成本占比已经 超过硅料，且银价大幅波动对产业链盈利影响巨大，贱金属替代更加迫切。结合产业反馈当前在粉体、 浆料、电池环节的深度合作下铜代银已取得积极进展，若顺利产业化各参与环节均有望获得丰厚回报， 同时考虑周期底部技术扩散节奏更慢，浆料技术变革 ...

转自：智通财经 【招商证券(香港)：维持腾讯控股买入评级 目标价750港元】智通财经3月20日电，招商证券(香港)发布 关于腾讯控股（00700.HK）的研报，维持"买入"评级，目标价750.0港元。公司4Q25业绩符合预期，核 心业务稳健，AI投资加码有望强化长期竞争力。虽FY26E AI投入或压制短期利润，但游戏、广告及云 业务增长动能明确，SOTP估值具支撑。 ...

Core Viewpoint - The report from China Merchants Securities International lowers the target price for Tencent Holdings (00700) from HKD 766 to HKD 700, a decrease of 8.6%, while maintaining an "Overweight" investment rating [1][4]. Financial Performance - Tencent's Q4 performance for the previous year met expectations, leading to a 6% downward revision in the earnings forecast for the fiscal years 2026-27, primarily due to increased investments in artificial intelligence (AI) [1][4]. - The projected revenue and adjusted net profit growth for Tencent in fiscal year 2026 is estimated at 10% and 8%, respectively, with the new target price corresponding to a 21 times forecasted price-to-earnings (P/E) ratio for that year [1][4]. Valuation Comparison - Tencent's current valuation for fiscal years 2026/27 stands at 16 times and 14 times forecasted P/E ratios, which is in line with the company's historical average [1][4]. - In comparison, Chinese peers are valued at 14 times and 11 times, while U.S. peers are at 24 times and 20 times [1][4]. Growth Drivers - The report highlights several growth drivers for Tencent, including a strong social network moat, advancements in AI technology, accelerated advertising business, new game launches (e.g., "Honor of Kings: World" expected in April), commercialization of AI products, overseas opportunities, and profit margin improvements driven by AI [1][4].

Core Viewpoint - The report from China Merchants Securities International indicates a reduction in the target price for Tencent Holdings (00700) from HKD 766 to HKD 700, representing an 8.6% decrease, while maintaining an "Overweight" investment rating [1] Financial Performance - Tencent's Q4 performance for the previous year met expectations, leading to a downward revision of the earnings forecast for the fiscal years 2026-27 by 6% due to increased investments in the AI sector [1] - The projected revenue and adjusted net profit growth for Tencent in the fiscal year 2026 is estimated at 10% and 8%, respectively, with the new target price corresponding to a 21 times forecasted price-to-earnings ratio for 2026 [1] Valuation Comparison - Tencent's current valuation for the fiscal years 2026/27 stands at 16 times and 14 times forecasted price-to-earnings ratios, which aligns with the company's historical average [1] - In comparison, Chinese peers are valued at 14 times and 11 times, while U.S. peers are at 24 times and 20 times [1] Growth Drivers - The report highlights several growth drivers for Tencent, including a strong social network moat, advancements in AI technology, accelerated advertising business, new game launches (e.g., "Honor of Kings: World" expected in April), commercialization of AI products, overseas opportunities, and profit margin improvements driven by AI [1]

Group 1 - The core point of the news is that Aibo Medical (688050.SH) announced a share reduction plan by shareholder Mao Liping, who intends to reduce up to 1,934,000 shares, representing no more than 1% of the company's total share capital, through block trading within a specified period [1] - As of the announcement date, Mao Liping holds 5,604,413 shares, accounting for 2.90% of the total share capital, and together with his concerted actor Bai Ying, they hold a total of 11,304,459 shares, which is 5.85% of the total share capital [1] - Mao Liping's shares were acquired before the company's IPO and through capital reserve conversion, with specific shares becoming tradable on July 31, 2023, and June 5, 2024 [1] Group 2 - Aibo Medical's stock price hit a record low of 53.00 yuan during trading, marking the lowest price since its listing [2] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 29, 2020, with an initial issuance of 26.29 million shares at a price of 33.55 yuan per share, raising a total of 882 million yuan [2] - The net proceeds from the fundraising amounted to 804 million yuan after deducting issuance costs, which were used for various projects including capacity expansion and R&D for high-end ophthalmic medical devices [2] Group 3 - The company successfully issued 3,593,615 shares at a price of 79.20 yuan per share, raising a total of approximately 284.61 million yuan, with a net amount of about 280.61 million yuan after deducting issuance costs [3] - The total amount raised from the two fundraising activities is approximately 1.167 billion yuan [4]

Group 1 - The core point of the news is that Aibo Medical (688050.SH) announced a share reduction plan by shareholder Mao Liping, who intends to reduce his holdings by up to 1,934,000 shares, representing no more than 1% of the company's total share capital [1] - As of the announcement date, Mao Liping holds 5,604,413 shares, accounting for 2.90% of the total share capital, while together with his concerted actor Bai Ying, they hold a total of 11,304,459 shares, which is 5.85% of the total share capital [1] - Mao Liping's shares were acquired before the company's IPO and through capital reserve conversion after the listing, with these shares set to be tradable on July 31, 2023, and June 5, 2024, respectively [1] Group 2 - Aibo Medical's stock price hit a record low of 53.00 yuan during trading, marking the lowest price since its listing [2] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 29, 2020, with an issuance of 26.29 million shares at a price of 33.55 yuan per share, raising a total of 882 million yuan [2] - The net proceeds from the fundraising amounted to 804 million yuan after deducting issuance costs, which were 78.04 million yuan, with the lead underwriter being China Merchants Securities [2] Group 3 - The company issued 3,593,615 shares at a price of 79.20 yuan per share, raising a total of 284,614,308 yuan, with net proceeds of 280,612,310.30 yuan after deducting issuance costs [3] - The total amount raised from the two fundraising events is 1.167 billion yuan [4]

Group 1 - The core point of the news is that Aibo Medical (688050.SH) announced a share reduction plan by shareholder Mao Liping, who intends to reduce his holdings by up to 1,934,000 shares, representing no more than 1% of the company's total share capital [1] - Mao Liping currently holds 5,604,413 shares, accounting for 2.90% of the total share capital, and together with his concerted action partner Bai Ying, they hold a total of 11,304,459 shares, which is 5.85% of the total share capital [1] - Aibo Medical's stock price hit a new low of 53.00 yuan during trading, marking the lowest price since its listing [1] Group 2 - The company raised a total of 882 million yuan, with a net amount of 804 million yuan after deducting issuance costs, which is 3.7865 million yuan more than the original plan [2] - The funds raised are intended for expanding production capacity and automation for ophthalmic lenses and related products, R&D for high-end ophthalmic medical devices and high-value consumables, marketing network and information technology construction, and supplementing working capital [2] - The total amount raised from two fundraising rounds is 1.167 billion yuan [3]

Core Viewpoint - Century Hengtong (301428.SZ) announced that part of the shares held by its controlling shareholder and actual controller, Yang Xinghai, have been judicially frozen, which may impact the company's governance and stock performance [1] Shareholder Information - Yang Xinghai holds a total of 34,530,000 shares, representing 35.00% of the company, with 11,330,000 shares frozen, accounting for 32.81% of his holdings and 11.48% of the company's total share capital [2] Financial Performance Forecast - For the fiscal year 2025, the company expects a net loss attributable to shareholders of between 35 million and 60 million yuan, with a net loss of 35 million to 55 million yuan after excluding non-recurring gains and losses [3] Historical Financial Comparison - The projected net loss for 2025 contrasts sharply with a profit of 61.91 million yuan in the same period last year, and a profit of 39.02 million yuan after excluding non-recurring items [3] IPO and Fundraising Details - Century Hengtong went public on May 19, 2023, issuing 24,666,667 shares at a price of 26.35 yuan per share, raising a total of approximately 649.97 million yuan, with a net amount of 563.68 million yuan after expenses [3] Use of Proceeds - The company initially planned to raise 334.68 million yuan for projects including the development of a car owner service support platform and the construction of a major customer development center, but the actual net fundraising exceeded the original target by 22.90 million yuan [3] Underwriting Information - The lead underwriter for the IPO was China Merchants Securities, with total issuance costs amounting to 86.29 million yuan, of which 51 million yuan was paid to the underwriter for sponsorship and underwriting services [4]

Group 1 - The core viewpoint of the report from China Merchants Securities maintains a "recommended" investment rating for the aviation industry, emphasizing the impact of Middle Eastern geopolitical situations on oil prices and ticket prices' ability to cover fuel costs [1] - The demand for air travel during the Spring Festival has shown significant growth, with a cumulative passenger volume increase of 4.6% year-on-year over 40 days, domestic passenger flow up by 5.5%, and a rise in average ticket prices by 3.8%, alongside a 1.7 percentage point increase in seat occupancy rates [1] - The report highlights the volatility of jet fuel prices influenced by crude oil prices and the crack spread, which is affected by refining capacity, market demand, and geopolitical factors [1] Group 2 - The domestic aviation kerosene pricing mechanism has evolved through three stages, resulting in a market-oriented linkage mechanism based on the average price of Singapore jet fuel, adjusted monthly [2] - The report estimates that with Brent crude oil priced at $80 per barrel and Singapore jet fuel at $110 per barrel, the average fuel surcharge would be approximately 72 yuan per person, requiring a 1% increase in base ticket prices and an 8% increase in full ticket prices to offset the impact of rising oil prices [2] - Historical context shows that in 2018, domestic airlines benefited from ticket price reforms, leading to an overall improvement in revenue levels, while in 2022, the industry faced significant losses due to high oil prices and the pandemic, with a 40% year-on-year decline in passenger turnover [2]

Group 1 - The core viewpoint of the article is that招商证券国际 has set a target price of HKD 32 for 吉利汽车 (Geely Automobile) and maintains a "Buy" rating, indicating optimism about the company's value amidst a recovering automotive sector [1] - The current pessimistic expectations in the automotive sector have been fully released, and valuations remain at historically low levels, suggesting potential for growth [1] - The report highlights the positive outlook for leading automotive companies, recommending 吉利汽车, 比亚迪股份 (BYD), and 小鹏汽车-W (Xpeng Motors), while also noting short-term trading opportunities in 蔚来-SW (NIO) [1] Group 2 - On March 16, 极氪 (Zeekr) launched its new high-performance five-seat flagship SUV, the 极氪8X, with a pre-sale price range of RMB 376,800 to RMB 516,800 [1] - The pre-sale saw over 10,000 orders within 38 minutes, with demand continuing to rise towards 20,000 orders, indicating strong market interest [1] - As of the evening of March 16, total orders reached 17,000, with 29% of orders for the high-end version, suggesting a strong preference for higher configurations among consumers [1] - The expectation is that orders will further increase after the official launch in April, as new vehicles typically come with price or benefit adjustments [1] - The product matrix of 极氪 is moving upwards, reinforcing its positioning as a high-end brand, which may lead to a positive shift in profitability expectations [1]